Gsk Plc (GSK.LN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2016 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 6,092,000 | 4,707,000 | 3,874,000 | 3,833,000 | 4,897,000 |
| Marketable Securities | 78,000 | 79,000 | 84,000 | 78,000 | 89,000 |
| Inventories | 5,996,000 | 5,947,000 | 5,476,000 | 5,557,000 | 5,102,000 |
| Other current assets | 7,722,000 | 8,442,000 | 7,163,000 | 6,131,000 | 6,288,000 |
| TOTAL | $20,247,000 | $19,491,000 | $16,927,000 | $15,907,000 | $16,711,000 |
| Non-Current Assets | |||||
| PPE Net | 11,006,000 | 11,314,000 | 11,058,000 | 10,860,000 | 10,808,000 |
| Intangibles | 40,421,000 | 41,517,000 | 22,991,000 | 23,296,000 | 24,741,000 |
| Other Non-Current Assets | 8,757,000 | 7,370,000 | 7,090,000 | 6,318,000 | 6,821,000 |
| TOTAL | $60,184,000 | $60,201,000 | $41,139,000 | $40,474,000 | $42,370,000 |
| Total Assets | $80,431,000 | $79,692,000 | $58,066,000 | $56,381,000 | $59,081,000 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 3,495,000 | 6,678,000 | 5,769,000 | 2,802,000 | 4,106,000 |
| Accounts payable and accrued liabilities | 4,357,000 | 4,144,000 | 3,645,000 | 3,528,000 | 3,596,000 |
| Other current liabilities | 765,000 | 755,000 | 837,000 | 1,076,000 | 561,000 |
| TOTAL | $22,148,000 | $24,050,000 | $22,491,000 | $26,569,000 | $19,001,000 |
| Non-Current Liabilities | |||||
| Long Term Debt | 22,538,000 | 22,580,000 | 20,227,000 | 14,221,000 | 14,620,000 |
| Other Non-Current Liabilities | 4,208,000 | 2,909,000 | 11,145,000 | 7,106,000 | 14,683,000 |
| TOTAL | $37,475,000 | $37,285,000 | $31,903,000 | $26,323,000 | $35,117,000 |
| Total Liabilities | $59,623,000 | $61,335,000 | $54,394,000 | $52,892,000 | $54,118,000 |
| Shareholders' Equity | |||||
| Common Shares | 1,346,000 | 1,346,000 | 1,345,000 | 1,343,000 | 1,342,000 |
| Retained earnings | 6,755,000 | 4,530,000 | -2,137,000 | -6,477,000 | -5,392,000 |
| Other shareholders' equity | 3,205,000 | 2,355,000 | 2,061,000 | 2,047,000 | 2,220,000 |
| TOTAL | $14,587,000 | $11,405,000 | $4,360,000 | $-68,000 | $1,124,000 |
| Total Liabilities And Equity | $74,210,000 | $72,740,000 | $58,754,000 | $52,824,000 | $55,242,000 |